Moderna stock gains on raised COVID vaccine sales outlook

Moderna Stock Gains On Raised COVID Vaccine Sales Outlook

2 weeks from now

Aug 3, 2023  · Moderna (NASDAQ:MRNA) traded ~4% higher pre-market Thursday after the vaccine maker lifted its full-year outlook for its blockbuster COVID shot despite a ~94% …

seekingalpha.com

Moderna Reports Surprise Profit On Higher-Than-Expected COVID …

2 weeks from now

Nov 7, 2024  · Moderna still expects to make less from COVID vaccine sales this year than it did in 2023, however, and reaffirmed its 2024 sales forecast of $3 billion to $3.5 billion. The …

usnews.com

Moderna Stock Gains On Better-Than-Expected Covid-19 Vaccine …

2 weeks from now

Nov 7, 2024  · Covid vaccine sales totaled $1.8 billion for the third quarter. That blew past analysts’ estimates of $1.2 billion, and was slightly higher than a year earlier. Moderna's stock …

wsj.com

Moderna's Stock Pops After Biotech Ekes Out A Surprise Profit, And ...

2 weeks from now

Nov 7, 2024  · Net product sales rose 4% to $1.8 billion in the quarter, driven by demand for the updated COVID-19 vaccine. Sales of Spikevax came to $1.8 billion, while FactSet was …

morningstar.com

Moderna Stock Surges 14% After Covid Vaccine-Maker Surprises …

2 weeks from now

Feb 22, 2024  · Moderna stock analysts model $321 million in sales of the company's vaccine this year. Mock notes Moderna's shot uses a pre-filled syringe, which could help it gain share from …

investors.com

After Earnings And A Big Selloff, Is Moderna Stock A Buy?

2 weeks from now

Aug 7, 2024  · Moderna’s massive covid-19 vaccine sales and prepayments left it with $18.2 billion in cash at the end of 2022, and given the firm’s lack of debt, financial strength looks solid. …

morningstar.com

Moderna Stock Surges After Covid Vaccine Sales Obliterate …

2 weeks from now

Aug 3, 2022  · Moderna also reiterated its view for $21 billion in full-year sales of its Covid vaccine. Analysts called for $22.2 billion in total revenue. Further, the company announced a new …

investors.com

Moderna Stock Forfeits Gains As First US Bird Flu Death Puts Vaccine ...

2 weeks from now

Jan 8, 2025  · After Moderna’s development of a COVID-19 vaccine fueled a massive surge in revenue — rising more than 2,000% in 2021 from the prior year, with the vaccine maker …

yahoo.com

Moderna Stock Slashes Hefty Premarket Gain With A Beat That's …

2 weeks from now

Nov 7, 2024  · This is evidenced by the fact Moderna retained its full-year outlook for $3 billion to $3.5 billion in sales. Further, sales of the respiratory syncytial virus vaccine, mResvia, came in …

investors.com

Moderna Raises Full-year COVID Vaccine Sales Forecast To $21

2 weeks from now

March 24 (Reuters) - Moderna Inc MRNA.O on Thursday raised its full-year forecast for sales of its COVID-19 vaccine to roughly $21 billion from $19 billion. The company in February forecast …

nasdaq.com

Moderna Cuts 2025 Sales Forecast By $1 Bln On Weak Vaccine …

2 weeks from now

2 days ago  · Moderna cut its 2025 sales forecast by $1 billion on Monday, hurt by a slow adoption of its respiratory syncytial virus (RSV) shot and weak demand for COVID-19 vaccines, sending …

reuters.com

Moderna's $1 Billion Revenue Forecast Cut Sends Stock

2 weeks from now

2 days ago  · Shares of Moderna dropped more than 20% intraday to $33.44, more than erasing gains last week after the first bird-flu death was reported in the U.S. The stock has lost about …

investopedia.com

Moderna Surges After CDC Reports Two-Week Covid Spike

2 weeks from now

Jan 7, 2025  · BioNTech and Novavax's Covid shots make up the entirety of their product sales. Moderna stock popped 11.7% to 47.53, while BioNTech shares 5.6% to 126.88. ... The lion's …

investors.com

Moderna Cuts Sales Forecast On Weaker Vaccine Demand - Yahoo …

2 weeks from now

2 days ago  · Moderna cut its 2025 forecast by $1 billion Monday, citing weak demand for its newest vaccine as well as slow sales for its COVID-19 vaccine. The company now expects …

yahoo.com

Stock Market Today: Gains For Oil Producers And Drops For Big Tech ...

2 weeks from now

2 days ago  · Moderna tumbled 16.8% for the largest loss in the S&P 500 after giving a forecast for revenue this upcoming year that fell short of analysts’ expectations. The vaccine maker, which …

apnews.com